QuantX Biosciences is an emerging computation-powered small molecule drug discovery company based in Princeton, New Jersey. QuantX has raised substantial Series A round led by OrbiMed and Creacion Ventures. QuantX aims to build a world class computational drug discovery platform by merging physics-based and statistical modeling, while fully utilizing an industry-leading high-performance computing resource. With a team of highly accomplished drug hunters, empowered and tightly integrated by the platform, we strive to discover breakthrough medicines.
